Pharma & Biotech

Following a successful restructuring of its balance sheet, GRI Bio is now channeling its resources into advancing the clinical programs...

Following its latest quarterly report, Benitec Biopharma is entering a pivotal stage in its corporate evolution. The initial market reaction...

Friday witnessed a dramatic sell-off in Grail's stock, triggered by disappointing news from a major clinical study. While the core...

Biotechnology firm Cassava Sciences has secured a significant legal victory with the U.S. Department of Justice (DOJ) formally closing its...

The French vaccine developer Valneva has released preliminary figures for 2025 and issued initial guidance for the current fiscal year....

Novo Nordisk has received crucial regulatory backing from Brussels, providing a positive counterpoint to recent stock market declines and heightened...

Pharmaceutical giant Eli Lilly & Co. has secured exclusive rights to a promising anti-inflammatory drug, marking another strategic move in...

The telehealth company Hims & Hers finds itself navigating a perfect storm of regulatory scrutiny and legal action, leading to...

Eli Lilly and Company is showcasing a multi-faceted growth strategy, with recent developments underscoring that its expansion is not solely...

ProPhase Labs is undergoing a significant portfolio review, with the potential sale of core business units now under consideration. The...